Global Bag Valve Masks Market USD 100 Million by 2020, Research Study by iHealthcareAnalyst, Inc.

The global bag value masks market by Product Types (BVM Disposable and BVM Reusable) 2016-2020 is estimated to reach USD 100 Million in 2020, growing at a CAGR of 5.2% from 2016 to 2020, published by iHealthcareAnalyst, Inc. - November 30, 2016 - iHealthcareAnalyst, Inc.

Global Medical Imaging Reagents Market USD 19.7 Billion by 2020 - iHealthcareAnalyst, Inc.

Medical Imaging Equipment Market – Product Types (Computed Tomography Scanners, Magnetic Resonance Imaging Equipment, Nuclear Imaging Equipment – PET, SPECT, Ultrasound Systems, X-Ray Devices) and Technologies (Computed Tomography Scanners, Magnetic Resonance Imaging Equipment, Nuclear Imaging Equipment – PET, SPECT, Ultrasound Systems – 2D, 3D, 4D, Doppler, High Intensity Frequency Ultrasound, Lithotripsy, X-Ray Devices – Analog, Computed, Digital Radiography) 2016-2020. - November 30, 2016 - iHealthcareAnalyst, Inc.

Global Anti-Aging Products and Services Market USD 300 Billion by 2020, Published by iHealthcareAnalyst, Inc.

Anti-Aging Products and Services Market – Product Types (Anti-Stretch Marks, Anti-Wrinkle, Botox, Dermal Fillers, Hair Color, UV Absorbers), Device Type (Anti-Cellulite Treatment, Laser Aesthetics, Microderm Abrasion, and Radiofrequency Devices), Service Types (Abdominoplasty, Adult Acne Therapy, Anti-Pigmentation Therapy, Breast Augmentation, Chemical Peel, Eye-Lid Surgery, Hair Restoration, Liposuction, and Sclerotherapy) 2016-2020 - November 30, 2016 - iHealthcareAnalyst, Inc.

Digital Health Startup Vitalistics Announces Public Launch

Vitalistics, a digital health startup transforming the overnight pulse oximetry and home sleep testing experience, launches today. - November 30, 2016 - Vitalistics

Research to be Presented at ASH Annual Meeting Shows Verseon’s New Class of Anticoagulants Prevents Thrombosis While Preserving Platelet Function

Verseon’s anti coagulants are as effective as NOACS at preventing arterial and venous thromboembolism and thrombin-induced pulmonary embolism. Lead candidate has low renal clearance compared to NOACS - highly desirable for patients with impaired renal function. - November 30, 2016 - Verseon

Global Dental Consumables Market USD 25.7 Billion by 2020, Published by iHealthcareAnalyst, Inc.

The global dental consumables market to reach nearly USD 25.7 Billion in 2020, at a CAGR of 6.8% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Dental Consumables Market Analysis and Forecast 2016-2020 report https://www.ihealthcareanalyst.com/report/dental-consumables-market/. Dental... - November 29, 2016 - iHealthcareAnalyst, Inc.

Global Autoimmune Disease Diagnostics Market USD 14.8 Billion by 2020, Market Study by iHealthcareAnalyst, Inc.

The global autoimmune disease diagnostics market was valued at USD 12.4 Billion in 2015 and is estimated to reach USD 14.8 Billion by 2020, at a CAGR of 3.6% from 2016 to 2020 - iHealthcareAnalyst, Inc. Browse the Autoimmune Disease Diagnostics Market Analysis and Forecast 2016-2020 at https://www. - November 29, 2016 - iHealthcareAnalyst, Inc.

Global Anesthesia Devices Market USD 9.6 Billion by 2020 - iHealthcareAnalyst, Inc.

The global anesthesia devices market was valued at USD 6.3 Billion in 2015 and is estimated to reach USD 9.6 Billion by 2020, at a CAGR of 8.8% from 2016 to 2020 - iHealthcareAnalyst, Inc. Browse the Anesthesia Devices Market Analysis and Forecast 2016-2020 at... - November 29, 2016 - iHealthcareAnalyst, Inc.

Social Determinants and Population Health: Moving Beyond Clinical Data in a Value-Based Healthcare System, December 8, 2016 Webinar

A December 8, 2016 webcast from the Healthcare Intelligence Network will examine opportunities available to healthcare providers to improve population health by going beyond traditional clinical factors to identify the social determinants impacting a person's health. - November 28, 2016 - Healthcare Intelligence Network

Global Cancer Technology, Inc. Signs Licensing Agreement with the University of California San Diego

Announcing an agreement to purchase patent and IP technology from UCSD for a novel way to track medical instruments using Nano Quantum Dots - November 25, 2016 - Global Cancer Technology, Inc

Forum for Drug Sponsors and Contract Development and Manufacturing Professionals Completes 2016 Program and Returns to Boston, San Diego and San Francisco in 2017

Outsourced Pharma’s final program in 2016 was recently concluded in San Francisco. For the first time, technology companies, venture capital firms and others from Silicon Valley and elsewhere were invited to join the Outsourced Pharma community to focus on the topic of “Drug Development... - November 25, 2016 - Outsourced Pharma Events

DelveInsight Announces End of the Year Discount on Reports

DelveInsight, a leading market research and consulting company, is offering discounts on its market research reports. - November 25, 2016 - DelveInsight

Zifo RnD Solutions Ranked Number 40 Fastest Growing Technology Company on the Deloitte Technology Fast 50™ India 2016

Attributes its 146% revenue growth to the Zifo team’s collective strength and commitment towards customer’s success. - November 23, 2016 - Zifo

Arch, Inc. and ROWhy Company Announce Toward Zero Co.

With the combined resources of Arch and ROWhy, Toward Zero Co., is ideally positioned to help move customers toward zero waste and tangible profit growth through integration of business and manufacturing systems with automation technology. - November 23, 2016 - Arch, Inc

Mayne Pharma Launches Temozolomide Capsules in U.S. – Generic Alternative to Temodar®

Mayne Pharma Inc. (Mayne Pharma) is pleased to announce the U.S. launch of temozolomide capsules, 5mg, 20mg, 100mg, 140mg, 180mg and 250mg, which is a generic version of branded Temodar®. Temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed cancerous... - November 23, 2016 - Mayne Pharma USA

ALFA Scientific Designs, Inc. Launches Redesigned Website to Drive User Experience

ALFA Scientific Designs, Inc. Launches Redesigned Website to Drive User Experience

A leader in rapid, point-of-care (POC) in-vitro diagnostic (IVD) device developer and manufacturer, ALFA Scientific Designs, Inc. has launched a newly redesigned website to better serve its customers. With updated modules, attention to user experience, and a clear design, ALFA has launched a... - November 22, 2016 - Alfa Scientific Designs

It’s What You Need: NAPHIA Releases 2016 Industry Insiders’ Report

This latest version of Industry Insiders’ Report is full of exclusive research, market metrics and private data from NAPHIA’s 2016 State of the Industry Report, as well as never-before shared gross written premiums from individual NAPHIA member-companies. This is information on companies and their performance that is not available anywhere else. - November 22, 2016 - NAPHIA - North American Pet Health Insurance Association

Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults

Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults

A new transdermal gel has been developed and is now available by prescription only to treat the symptoms of gout attacks. ColciGel® is a transdermal medication that provides rapid relief of pain at the first sign of acute gout flares without gastrointestinal problems. - November 22, 2016 - Gensco Pharma

CERTIFIED, INC. $20 Million Fundraising Acquisition

CERTIFIED, INC. $20 Million Fundraising Acquisition

CERTIFIED, INC. has announced an agreement with Switzerland based Galileo Asset Management SA (galileoam.com) to assist in the acquisition of $20 million of equity funding. Such funding will expedite CERTIFIED’s international distribution and usage of their breakthrough disruptive smartphone... - November 21, 2016 - CERTIFIED INC.

Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds

Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds

Astero® is indicated for painful wounds such as stage I-IV pressure ulcers, Venous stasis ulcers, ulcerations caused by mixed vascular etiologies, Diabetic skin ulcers, first and second degree burns, post-surgical incisions, cuts and abrasions. Astero® is specifically formulated to create a moist healing environment, which promotes granulation, epithelialization, and autolytic debridement, while providing prolonged anesthesia of the wound, lessening the need for systemic pain medications. - November 19, 2016 - Gensco Pharma

Mount Sinai Beth Israel Receive Award from the Department of Defense to Study Gulf War Illness with electroCore’s Non-Invasive Vagus Nerve Stimulation Therapy

The Pain & Fatigue Study Center at Mount Sinai Beth Israel in New York has been awarded a United States Army Medical Research grant to conduct a study into the treatment of veterans of the 1990-1991 Gulf War who have Gulf War Illness using electroCore’s non-invasive vagus nerve... - November 17, 2016 - electroCore

Transnetyx Nears 12 Million Samples Genotyped, Gives 700 Working Years Back to Research

Transnetyx Nears 12 Million Samples Genotyped, Gives 700 Working Years Back to Research

Transnetyx, an automated genotyping company, today announced that it will reach 12 million samples processed by the end of 2016. Since it began its operations in 2004, Transnetyx has served the research of more than 600 organizations – universities, hospitals and bioscience companies –... - November 16, 2016 - Transnetyx

New Gastrointestinal Pathogen Assays Available from ALPCO

New Gastrointestinal Pathogen Assays Available from ALPCO

ALPCO is now offering a line of research assays for the investigation of common bacterial and parasitic gastrointestinal (GI) pathogens including Giardia lamblia, Cryptosporidium spp., Blastocystis hominis, Entamoeba histolytica/dispar, and Clostridium difficile. These assays can be used to... - November 15, 2016 - ALPCO

Virun® Launches a Line of Shelf-Stable Probiotic Multi-Serving Powders and Emulsions

Virun® Launches a Line of Shelf-Stable Probiotic Multi-Serving Powders and Emulsions

Virun® NutraBiosciences® Technology Revolutionizes Probiotics with Non-refrigerated Probiotic Single-serving Powders and Emulsions Available to Manufacturers. - November 15, 2016 - VIRUN

Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023

DelveInsight, the leading market research and consulting company, has added a new report, Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2023, to its portfolio. - November 13, 2016 - DelveInsight

ITSENCLOSURES is Exclusive Supplier of Digital Signage Enclosures at COTA's CMAX Bus Stops

COTA, the Central Ohio Transit Authority, integrates outdoor LCD enclosures in the new CMAX bus shelters to display dynamic digital signage. - November 11, 2016 - ITSENCLOSURES

New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1

New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1

ALPCO has released its new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA, the most sensitive active GLP-1 assay on the market. - November 09, 2016 - ALPCO

The Precious You Launches Enhanced Multi Vitamins Under Its Brand Name, The Healthy You

The Precious You, a Georgia-based Health, Fashion and Lifestyle Company, announces the launch of its new Health Multi-Vitamins under the brand name The Healthy You. "We are very excited about the launch of a completely new Product Line under an established brand name as it gives our customer... - November 09, 2016 - The Precious You LLC

November 17 Webinar: Healthcare Publisher to Hold 13th Annual Industry Trends Strategic Planning Session

The Healthcare Intelligence Network will present its thirteenth annual roadmap to the key issues, challenges and opportunities healthcare organizations can expect to face in the coming year during "Trends Shaping the Healthcare Industry in 2017: A Strategic Planning Session," a November 17, 2016 webinar. - November 09, 2016 - Healthcare Intelligence Network

IQ4I Research & Consultancy Published a New Report on “Next-Generation Sequencing (NGS) Global Market – Forecast To 2022”

Next generation sequencing market is one of the fastest growing segments in the genomics market with high double digit CAGR in the next five years. Rapid adoption of this technology, increased accuracy, and affordable costs are the factors driving the market. - November 09, 2016 - IQ4I Research & Consultancy Pvt. Ltd.

ALFA to Feature Breakthrough Technology for Rapid Diagnostic Tests at MEDICA 2016

ALFA to Feature Breakthrough Technology for Rapid Diagnostic Tests at MEDICA 2016

ALFA Scientific Designs, Inc., a rapid immunoassay, point-of-care (POC) test development and manufacturing company based in San Diego, California, will exhibit at the MEDICA 2016 World Forum for Medicine in Düsseldorf Germany from November 14-17, 2016. ALFA will welcome visitors and customers... - November 08, 2016 - Alfa Scientific Designs

Tredence Announces Sponsorship of Tableau Conference 2016

Tredence Inc., provider of scalable analytics solutions, today announced, it will sponsor the Tableau Customer Conference 2016, being held from Nov 7 – 11 at the Austin Convention Center in Austin, TX. At the conference, Tableau customers, partners, and experts will come together to share... - November 08, 2016 - Tredence Inc.

Families of World War II Veterans Annual Golf Tournament Fundraiser

The Families of World War II Veterans annual scholarship fundraiser will be held on the shoreline of Lake Lewisville at the majestic Old American Golf Club on Thursday, November 10, 2016 – the day before Veterans Day. - November 07, 2016 - Careington

Orthobiologics Market USD 5.8 Billion by 2020, New Research Study by iHealthcareAnalyst, Inc.

Orthobiologics Market 2013-2020 report estimates the global orthobiologics market to reach nearly USD 5.8 Billion in 2020, at a CAGR of 6.2% from 2016 to 2020 - iHealthcareAnalyst, Inc. - November 04, 2016 - iHealthcareAnalyst, Inc.

Phi Life Sciences Accepted as a Qualified Business to Raise Capital by the South Carolina Secretary of State

Phi Life Sciences Accepted as a Qualified Business to Raise Capital by the South Carolina Secretary of State

Phi Life Sciences has registered and been accepted by the Secretary of State of South Carolina to be a qualified business under the High Growth Small Business Job Creation Act of 2013 (S.C. Code of Laws §§ 11-44-10 et. seq.). As a qualified business, Phi Life Sciences is now eligible to... - November 03, 2016 - Phi Life Sciences

Edupliance to Discuss Impact of Overtime Updates on Employers in Live Webinar on Nov 10, 2016

Edupliance holds a webinar with expert Susan Desmond on how employers can understand and plan for overtime pay and the impact of proposed changes by the Department of Labor. - November 03, 2016 - Edupliance

Life Science Reagents Market USD 28.6 Billion by 2020 - iHealthcareAnalyst, Inc.

Life Science Reagents Market 2013-2020 report estimates the global life science reagents market to reach nearly USD 28.6 Billion in 2020, at a CAGR of 10.7% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Life Science Reagents Market 2013-2020 report... - November 03, 2016 - iHealthcareAnalyst, Inc.

Metabolomics Market USD 1.24 Billion by 2020, Published by iHealthcareAnalyst, Inc.

The global metabolomics market is estimated to reach USD 1.24 Billion in 2020, growing at a CAGR of 15.6% from 2016 to 2020, according to a market research report Metabolomics Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Metabolomics Market 2013-2020 report at... - November 03, 2016 - iHealthcareAnalyst, Inc.

Human Insulin Market USD 32.8 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.

Tthe global human insulin market is estimated to reach USD 32.8 Billion in 2020, expanding at a CAGR of 4.8% from 2016 to 2020. - November 03, 2016 - iHealthcareAnalyst, Inc.

NuvOx Pharma Awarded NIH Grant to Develop Technology to Increase Sensitivity and Specificity of Breast Cancer Diagnosis

NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the National Cancer Institute for $298,820.00 entitled, “B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast Cancer.” Evan Unger, MD, co-founder of NuvOx, a co-principal investigator of the... - November 03, 2016 - NuvOx Therapeutics

Viral Vectors and Plasmid DNA Manufacturing to Witness 16% Annual Growth, Predicts Roots Analysis

Roots Analysis has announced the addition of the “Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026” report to its portfolio. The report features an extensive study of the rapidly growing market of gene therapy vectors. Kashish Goel, the principal analyst, said, “Gene... - November 02, 2016 - Roots Analysis

Global Albumin Market USD 300 Million by 2020, Research Study Published by iHealthcareAnalyst, Inc.

The global albumin market is estimated to reach USD 300 Million in 2020, expanding at a CAGR of 2.4% from 2016 to 2020. - November 01, 2016 - iHealthcareAnalyst, Inc.

Nanomedicine Market USD 170 Billion by 2020, Published by iHealthcareAnalyst, Inc.

The global nanomedicine market is estimated to reach USD 170 Billion in 2020, growing at a CAGR of 8.9% from 2016 to 2020, according to a market research report Nanomedicine Market 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Nanomedicine Market 2013-2020 report at... - November 01, 2016 - iHealthcareAnalyst, Inc.

Radiopharmaceuticals Market USD 350 Million by 2020 - iHealthcareAnalyst, Inc.

Radiopharmaceuticals Market 2013-2020 report estimates the global radiopharmaceuticals market to reach nearly USD 350 Million in 2020, at a CAGR of 4.9% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Radiopharmaceuticals Market 2013-2020 report... - November 01, 2016 - iHealthcareAnalyst, Inc.

Nonalcoholic Steatohepatitis Treatment Market USD 19.8 Billion by 2025, Research Study by iHealthcareAnalyst, Inc.

The global nonalcoholic steatohepatitis treatment market is estimated to reach USD 19.5 Billion in 2025, expanding at a CAGR of 10.0% from 2016 to 2025. - October 30, 2016 - iHealthcareAnalyst, Inc.

Periodontal Disease Therapeutics Market USD 160 Million by 2020, Published by iHealthcareAnalyst, Inc.

The global periodontal disease therapeutics market is estimated to reach USD 160 Million in 2020, growing at a CAGR of 8.2% from 2016 to 2020, according to a market research report Periodontal Disease Therapeutics Market, 2013-2020, published by iHealthcareAnalyst, Inc. Visit the Periodontal... - October 30, 2016 - iHealthcareAnalyst, Inc.

Ultraviolet Germicidal Irradiation Market USD 300 Million by 2020 - iHealthcareAnalyst, Inc.

Ultraviolet Germicidal Irradiation Market 2013-2020 report estimates the global ultraviolet germicidal irradiation market to reach nearly USD 300 Million in 2020, at a CAGR of 9.9% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Ultraviolet Germicidal Irradiation Market 2013-2020 report... - October 30, 2016 - iHealthcareAnalyst, Inc.

Graves’ Disease - Market Insights, Epidemiology and Market Forecast

DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. - October 30, 2016 - DelveInsight

Mayne Pharma Launches Budesonide Capsules in the United States

Mayne Pharma announces the U.S. launch of budesonide capsules in a 3 mg dose. Budesonide is a generic alternative to Entocort EC®, which is used as a treatment for patients with mild to moderate Crohn’s disease. The capsules reflect the company's focus on developing and manufacturing controlled-release and potent pharmaceuticals. - October 29, 2016 - Mayne Pharma USA

Menopausal Hot Flashes Therapy Market USD 4.7 Billion by 2020 - iHealthcareAnalyst, Inc.

Menopausal Hot Flashes Therapy Market 2013-2020 report estimates the global menopausal hot flashes therapy market to reach nearly USD 4.7 Billion in 2020, at a CAGR of 3.8% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Menopausal Hot Flashes Therapy Market 2013-2020 report... - October 29, 2016 - iHealthcareAnalyst, Inc.

Press Releases 2,251 - 2,300 of 8,731